| 659
Genes to Cells NOSHIRO et al. (Mohawk et al., 2012; Shostak et al., 2013) . Several studies have shown that clock components, such as CLOCK and BMAL1, are involved in the regulation of adipogenesis and lipogenesis, and these factors are consequently also related to obesity (Paschos et al., 2012; Turek et al., 2005; Zanquetta, Correa-Giannella, Monteiro, & Villares, 2010) . In addition, another clock regulator PER2 controls lipid metabolism by interacting with PPARγ (Grimaldi et al., 2010) . These facts suggest that the clock system plays a role in the development of obesity through the disruption of lipid homeostasis.
The basic helix-loop-helix transcription factor, DEC1 (also known as BHLHE40, Stra13 or Sharp2), and the structurally related protein, DEC2 (also known as BHLHE41 or Sharp1), are ubiquitously expressed and implicated in neurogenesis (Rossner, Dorr, Gass, Schwab, & Nave, 1997) , cell growth arrest (Sun & Taneja, 2000) , chondrogenesis (Shen et al., 2002) and carcinogenesis (Miyazaki et al., 2002) . DEC1 and DEC2, the expression of which is regulated by the CLOCK:BMAL1 heterodimer through the CACGTG Ebox, are also involved in a core feedback loop of the molecular clock system (Honma et al., 2002; Kato, Kawamoto, Fujimoto, & Noshiro, 2014; Nakashima et al., 2008) . In addition, our previous study showed that forced expression of DEC1 suppressed the adipogenic differentiation of human mesenchymal stem cells (Iwata et al., 2006) . Other studies have also reported the involvement of DEC1 in adipogenesis (Park & Park, 2012; Yun, Maecker, Johnson, & Giaccia, 2002) . These findings suggest that DEC1 plays an important role in the control of adipogenesis and lipid metabolism.
In this study, we show that DEC1 deficiency prevents obesity in mice fed a high-fat diet. We also demonstrate that DEC1 suppresses the expression of lipolysis-related genes in brown adipose tissue (BAT) through binding to the PPARγ: retinoid X receptor α (RXRα) heterodimer, which is a key regulator of adipogenesis and lipid metabolism (Lefterova et al., 2008; Nielsen et al., 2008; Wakabayashi et al., 2009 ).
| RESULTS

| DEC1 deficiency attenuates high-fatdiet-induced obesity
In our previous study, we established Dec1 −/− mice (Nakashima et al., 2008) and confirmed DEC1 deficiency in the adipose tissues and liver used in this study (see Figure 3b ). Although DEC1 has been suggested to be involved in adipogenic differentiation (Iwata et al., 2006; Park & Park, 2012; Yun et al., 2002) , the body weight of Dec1 −/− mice is almost the same as that of wild-type (WT) mice ( Figure 1a ). We therefore assessed whether DEC1 deficiency affects obesity or other disorders related to lipid metabolism when mice are fed a high-fat diet. When fed such a diet from 4 weeks of age,
Dec1
−/− mice gained less weight than WT mice, and the difference became more pronounced with age ( Figure 1a ) even though food intake per body weight by these mice was similar throughout the experimental period (data not shown).
To assess the increase in the volumes of subcutaneous and visceral fat, we investigated the distribution of fat depots in the abdomen of 14-week-old mice (10 weeks into the feeding diet) using microcomputed tomography (micro-CT). The abdominal midsection between the L1-L6 lumbar vertebrae, which correlates with total adiposity and explanted fat pad weight (Lubura et al., 2012) , was selected for this analysis; the total and fat volumes of this region were significantly smaller in Dec1 −/− mice than in WT on both control and high-fat diets (Figure 1b, c) . Taken together, these data suggest that DEC1 deficiency suppresses the body weight gain, probably due to the decrease in lipid accumulation, although body weight gain was not significantly different between WT and Dec1 −/− mice on the control diet.
| DEC1 deficiency reduces lipid accumulation in white adipose tissue (WAT), BAT and liver
Histological examination showed that adipocytes in WAT became hypertrophic in both WT and Dec1 −/− mice fed a highfat diet (Figure 1d ). However, adipocytes in Dec1 −/− mice were apparently smaller than those in WT. Average sizes of adipocytes in WAT were 68.5 ± 0.6 and 49.9 ± 0.5 μm in WT and Dec1 −/− mice fed a control diet, respectively, and 103.0 ± 1.1 and 86.9 ± 0.9 in WT and Dec1 −/− mice fed a high-fat diet, respectively ( Figure 1e ). Thus, DEC1 deficiency significantly reduced adipocyte size in mice fed both control and high-fat diets compared with the WT mice under the same dietary regimens. Decreased lipid accumulation was observed in the BAT of Dec1 −/− mice in both control and high-fat diet groups compared with WT mice (Figure 1f, g ). The lipid-accumulated area in the liver was also smaller in Dec1 −/− mice fed a highfat diet than that in WT mice (Figure 1h , i). In addition, when fed a high-fat diet, WT mice appeared to develop severe hepatic steatosis compared with Dec1 −/− mice ( Figure 1j ).
These findings suggest that DEC1 deficiency prevents obesity through decreased lipid accumulation in adipose tissues and the liver.
| DEC1 deficiency increases body temperature and Ucp1 expression in BAT
It is likely that increased energy consumption in the body attenuates obesity or hepatic steatosis in Dec1 −/− mice. As DEC1 is a member of the molecular clock system (Honma et al., 2002; Kato et al., 2014) , it is necessary to examine the effect of DEC1 deficiency at least twice a day. As a result, we measured the core temperature of mice at Zeitgeber time (ZT) 2 and ZT14, corresponding to the times of trough and peak core temperatures, respectively, in normal mice (Hannibal, Hsiung, & Fahrenkrug, 2011) . The core temperature at ZT14 was almost equal in the four groups of mice, irrespective of diet or genotype. However, the core temperature of Dec1 −/− mice at ZT2, which is the resting phase during the daytime, was significantly higher than that of WT mice on both diets ( Figure 2a ). In Dec1 −/− mice fed a high-fat diet, the core temperature at ZT2 and ZT14 was almost the same ( Figure 2a ). The increase in the core temperature of Dec1 −/− mice over WT at ZT2 suggested that energy consumption and thermogenesis, which are crucial for body temperature control, were enhanced. Therefore, we examined the expression of uncoupling protein 1 (Ucp1), which is preferentially expressed in BAT and is responsible for thermogenesis (Richard & Picard, 2011) . Ucp1 expression increased in the BAT of WT and Dec1 −/− mice fed a high-fat diet; Ucp1 levels were higher in Dec1 −/− mice than in WT under the same dietary condition (Figure 2b ). The increase in Ucp1 expression in the BAT of Dec1 −/− mice fed a high-fat diet was more prominent at ZT2, which is the time point at which the core temperature was elevated.
| DEC1 deficiency increases gene expression related to lipid metabolism in BAT
As UCP1-dependent thermogenesis requires the supply of lipids as substrates (Cannon & Nedergaard, 2004) , we examined the expression of the following lipolysis-related genes: lipoprotein lipase (Lpl), a gene involved in the uptake of fatty acid from the plasma into cells (Schoonjans et al., 1996) ; carnitine palmitoyltransferase 1b (Cpt1b), an essential gene for the uptake of fatty acids into mitochondria for β-oxidation (Zhang et al., 2016) ; cytochrome c oxidase subunit IV (Cox4) and ATP synthase F1 complex β subunit (Atp5b), genes coding for mitochondrial electron transport proteins (Sun et al., 2015) ; several isoforms of acyl-CoA dehydrogenase (Acad1, Acad4 and Acad6), genes of key enzymes in fatty acid β-oxidation (Gulick, Cresci, Caira, Moore, & Kelly, 1994) ; and Pparγ, a key transcription factor gene involved in lipid metabolism. In both genotypes, the high-fat diet enhanced the expression of most of these genes in BAT ( Figure 3a ). DEC1 deficiency also increased their mRNA levels at ZT2 or ZT14, or both. In contrast, transcript levels of these genes in WAT and liver were very low and did not significantly differ between the two genotypes, irrespective of the diet, although Lpl and Pparγ were also expressed at high levels in WAT. Thus, DEC1 deficiency significantly increased the expression of Ucp1 as well as genes involved in fatty acid β -oxidation and mitochondrial energy metabolism in BAT, likely causing the higher body temperature ( Figure 2a ) and decreased fat depots (Figure 1b, c) observed in these animals. DEC2 (a DEC1 isoform) could not compensate for DEC1 deletion in BAT because Dec2 expression was not up-regulated in the BAT of Dec1 −/− mice ( Figure 3b ).
| DEC1 directly suppresses the activity of the PPARγ:RXRα heterodimer
Next, the underlying mechanism by which DEC1 affects gene expression was investigated. Ucp1, Acad1, Acad4 and Acad6, along with Cpt1b, Cox4, Atp5b and Lpl, which showed altered expression in the BAT of Dec1 −/− mice (see above), are targets of PPARγ (Lefterova et al., 2008; Nielsen et al., 2008; Wakabayashi et al., 2009) . Because PPARγ induces transcription of these genes by binding to PPAR responsive elements (PPREs) as a heterodimer with RXRα, we examined whether DEC1 modulates the transcriptional activity of the consensus PPRE (Lemay & Hwang, 2006) in the presence of the PPARγ:RXRα heterodimer using luciferase reporter assays. The luciferase activity of the consensus PPRE reporter was enhanced by the PPARγ:RXRα heterodimer in 3T3-L1 differentiated adipocytes; the transactivation by the PPARγ:RXRα heterodimer was significantly suppressed by DEC1, although the activity of the reporter was not affected by DEC1 alone (Figure 4a ). To examine the interaction of DEC1 with PPARγ target genes in cells, we carried out chromatin immunoprecipitation (ChIP) assays using 3T3-L1 cells; anti-DEC1 antibodies; and primer sets for the Lpl, perilipin 1 (Plin1: lipid droplet-associated protein) and Pparγ genes Schoonjans et al., 1996) . Using the anti-DEC1 immunoprecipitates or the input samples from 3T3-L1 adipocytes as a template, PCR products with the expected sizes for the respective PPRE regions were generated (Figure 4b ). These findings demonstrate that DEC1 binds to the PPRE region of PPARγ target genes in cells, probably through binding to the PPARγ:RXRα heterodimer. Cho et al. (2009) have already demonstrated that DEC1 suppresses transcriptional activation by nuclear receptors such as liver X receptor α, farnesoid X receptor, vitamin D receptor and retinoic acid receptor α through direct binding to their heterodimerization partner, RXRα. We therefore examined whether DEC1 binds to PPARγ or RXRα to inhibit the activity of the PPARγ:RXRα heterodimer. We transfected expression plasmids for FLAG-DEC1, RXRα and PPARγ into human embryonic kidney (HEK) 293 cells and examined their interaction by immunoprecipitation using anti-FLAG antibodies. RXRα coprecipitated with FLAG-DEC1, whereas PPARγ was detected only in the presence of both FLAG-DEC1 and RXRα (Figure 4c ), indicating that DEC1 directly associates with RXRα, but not with PPARγ. These results, together with those of the luciferase reporter ( Figure 4a ) and ChIP (Figure 4b ) assays, demonstrate that DEC1 interacts with RXRα at the PPREs in the PPARγ target genes and thereby suppresses PPARγ:RXRα heterodimerinduced transactivation.
| DISCUSSION
Here, we examined the effects of DEC1 deficiency on obesity-related phenotypes such as body weight gain, lipid accumulation and thermogenesis in mice. The body weight of Dec1 −/− mice fed a high-fat diet was lower than that of WT mice maintained under the same conditions; fat volume in the abdomen of Dec1 −/− mice was significantly smaller than that of WT. In addition, body temperature increased in Dec1 −/− mice compared with WT mice. In the same way, the expression of various lipid-metabolizing genes in Dec1 −/− mice was up-regulated in BAT, the major site of thermogenesis, but not in WAT and the liver. DEC1 suppressed the transcriptional activity of the PPARγ:RXRα-heterodimer, a key transcription factor in lipid metabolism, by directly binding to RXRα. These results suggest that DEC1 is a potent regulator of lipid and energy metabolism and that suppressive regulation by DEC1 via binding to the PPARγ:RXRα heterodimer is an effective way to save lipid energy. Genome-wide analyses identified more than 5,000 binding sites of the PPARγ:RXRα heterodimer in adipocytes (Lefterova et al., 2008; Nielsen et al., 2008; Wakabayashi et al., 2009 ). Most lipid-metabolizing genes influenced by DEC1 deficiency are included in the lists of PPARγ target genes in those reports. Figure 5 illustrates the possible effects of DEC1 deficiency in reducing the development of obesity by the transcriptional regulation of PPARγ target genes via PPREs involved in lipid consumption in BAT, the lipid flow from WAT to BAT and the accumulation of lipid in WAT. DEC1 deletion results in the up-regulation of Ucp1 and many lipolysis-related genes responsible for β-oxidation (Acad), lipid transport (Lpl and Cpt1b) and electron transport (Cox4 and Atp5b) in BAT, leading to increased lipid consumption and thermogenesis, which require the enhancement of lipid supply from WAT to BAT. A recent study has demonstrated that BAT is a master regulator of triglyceride clearance: It efficiently consumes fatty acids according to a metabolic program (Bartelt et al., 2011) . Accelerated lipid intake and consumption in the BAT of Dec1 −/− mice may result in a decrease in lipid accumulation and adipocyte size in WAT, leading to the prevention of obesity. In addition, the increased consumption of lipids in DEC1-deficient BAT appears to reduce the development of hepatic steatosis, the ectopic accumulation of lipids in the liver. Similar to this study, Cho et al. (2009) demonstrated that DEC1 could bind to RXRα via an LxxLL motif in DEC1, a motif typically found in cofactors of nuclear receptors (Rosenfeld, Lunyak, & Glass, 2006) , to repress the transactivation activity of nuclear receptors that function with RXRα as a partner, such as the liver X receptor α, farnesoid X receptor, vitamin D receptor and retinoic acid receptor α, although in vivo effects were not demonstrated. The results in this study demonstrate that DEC1 represses the transactivation activity of another partner of RXRα, that is PPARγ, and thereby regulates lipid metabolism in BAT. To our knowledge, this is the first report to illustrate the in vivo action of DEC1 through binding to RXRα. Most lipid-metabolizing genes examined in the present study were expressed at high levels and influenced by DEC1 deficiency in BAT, whereas the same genes were expressed at low levels and not necessarily affected by DEC1 deficiency in the liver. These differences may be partly due to the minor contribution of PPARγ to the regulation of lipid metabolism in the liver. In fact, the expression of Pparγ was substantially lower in the liver than in BAT. In addition, DEC2 may compensate for the loss of DEC1, because Dec2 expression was markedly up-regulated in the Dec1 −/− liver. These findings may explain why we observed no significant differences in the transcript levels of hepatic genes for lipid metabolism in Dec1 −/− mice.
Although most hepatic genes examined in the present study are PPARγ target genes, there may be additional regulatory factors controlling these genes, which need to be elucidated in future studies. Various physiological functions, including body temperature, exhibit circadian rhythms that are, directly or indirectly, under the control of the master circadian factor, the CLOCK:BMAL1 heterodimer (Mohawk et al., 2012) . CLOCK:BMAL1 activates clock genes through binding to E-boxes, while DEC1 participates in the circadian regulation by competing with CLOCK:BMAL1 for binding to the same E-boxes (Honma et al., 2002; Kawamoto et al., 2004) . Oishi et al. (2006) reported that the disruption of CLOCK function attenuated high-fat-diet-induced obesity. However, DEC1 deficiency led to similar results in this study to those reported. In addition, we found that body temperature increased in Dec1 −/− mice at ZT2, but not at ZT14, when compared with WT mice, resulting in the disruption of the day-night difference. Moreover, all of the PPARγ target genes examined in this study were up-regulated in Dec1 −/− BAT, at least at ZT14. Although the expression of Dec1, as well as Dec2, exhibited a day-night difference, the expression of most genes governed by PPARγ did not (shown in Figure 3) , suggesting that these genes are not direct targets of CLOCK:BMAL1. Therefore, DEC1 may influence circadian rhythms in lipid metabolism-related activities such as thermogenesis through interaction with PPARγ:RXRα, but not through the interaction with CLOCK:BMAL1, suggesting another mechanism underlying the circadian regulation of PPARγ target genes. In fact, DEC1 deficiency almost disrupted the circadian rhythm of core temperature and prevented high-fat-dietinduced obesity, possibly due to the up-regulation of Ucp1 in ZT2. Further studies are needed to uncover the finer details of the physiological role of DEC1 in lipid metabolism and thermogenesis.
In the present study, we obtained some inconsistent results, reason for which is difficult to explain. First, core temperature in Dec1 −/− mice was significantly increased in ZT2 but not in ZT14 compared with the WT mice, although Ucp1 expression was up-regulated in both ZT2 and ZT14.
The time lag between circadian phases of rhythms of Ucp1 expression and core temperature may explain the observed difference. Several factors other than UCP1 involved in thermogenesis may also explain this discrepancy. Second, the fat volume of the abdominal region was significantly smaller in Dec1 −/− mice than in WT mice fed a control or high-fat diet. However, we found no difference in body weight between WT and Dec1 −/− mice fed a control diet from 5 to 16 weeks, although there was a significant decrease in body weight of Dec1 −/− mice at 4 weeks. In fact, there are unknown mechanisms compensating these differences through uncharacterized pathways. The increased core temperature and the decreased body weight and fat volume observed in Dec1 −/− mice could be influenced by increased locomotor activity. However, the observed locomotor activities were not significantly different between WT and Dec1 −/− mice fed a control diet (unpublished data), although the activities of mice fed a high-fat diet were not examined. Future research should focus on phenotypes other than lipid metabolism under both high-fat and control diet conditions. In nature, animals often face starvation; obese animals in the natural environment are uncommon. In this context, DEC1 appears to serve as a "energy-saving" factor to survive starvation. However, in the modern human lifestyle, energysaving factors such as DEC1 may promote obesity under excess nutrition conditions. In addition, DEC1 can be induced by environmental stimuli such as light and feeding (Honma et al., 2002; Kato et al., 2014; Kawamoto et al., 2006) , and this elevated DEC1 expression may further promote obesity. We anticipate that our findings may provide new therapeutic and prophylactic avenues for the prevention and mitigation of obesity-related diseases.
| EXPERIMENTAL PROCEDURES
| Animals
Male C57BL/6J WT and Dec1 −/− mice (Nakashima et al., 2008) were housed under a 12-h light/dark cycle at a constant temperature and given food and water ad libitum. All manipulations during the dark phase were carried out using night vision goggles (Bushnell Corp.) or under a red dim light to avoid disruptions of circadian rhythms. All procedures were carried out in compliance with standard principles and guidelines for the care and use of laboratory animals at Hiroshima University Institute of Biomedical and Health Sciences under the ethical permission of Animal Research Committee of Hiroshima University. For the high-fat diet experiment, 4-week-old male WT and Dec1 −/− mice were divided into two groups that were fed either a high-fat diet (82% kcal fat, 15% kcal protein and 3% kcal carbohydrate; F2HFHSD; Oriental Yeast Co.
Ltd) or a control diet (40.6% kcal fat, 17.6% kcal protein and 41.8% kcal carbohydrate; AIN93G). Mice were differentiated by ear punches. Weight and core temperature were measured weekly, and core temperature was monitored using a BAT-12 Microprobe Thermometer equipped with a rectal probe for mice (Muromachi Kikai Co., Ltd). After 10-13 weeks, mice were scanned by micro-CT or killed and subjected to histological analysis and RNA extraction.
| Isolation of RNA and quantitative real-time RT-PCR analysis
At 13 weeks after the initiation of the feeding experiment, 4-5 mice from each group were decapitated at the indicated time points in a normal light/dark cycle. All RNA preparations were obtained separately from visceral WAT, interscapular BAT and liver of individual mice, and used to measure the transcript levels of various genes, as described previously (Ozaki et al., 2012) . Quantitative real-time RT-PCR analysis was carried out using the ABI PRISM 7900 Sequence Detection System (Applied Biosystems) as described (Gibson, Heid, & Williams, 1996) . First-strand cDNA synthesis and the sequences of the primers and TaqMan ™ fluorogenic probes (Applied Biosystems) for mice Dec1 and Dec2 have been described previously (Noshiro et al., 2005) . The sequences of the primers and TaqMan ™ fluorogenic probes for the other genes were designed using the ProbeFinder ™ software of the Roche Universal Probe Library system (Roche Applied Science). The sequences and probe IDs are listed in Table 1 .
| Micro-CT scan analysis of mouse fat
At 10 weeks after the initiation of the feeding experiment, mice were anesthetized by an intraperitoneal injection of pentobarbital (50 mg/kg body weight) and positioned with both legs fully extended. The body of each mouse was scanned at 36 μm with a SkyScan 1176-HT (SkyScan Co.). 2D image slices of the abdominal region (between the proximal end of the first lumbar vertebra and the distal end of the sixth lumbar vertebra) were reconstructed into a 3D tomography image as shown in Figure 1b . The reconstituted visceral and subcutaneous fat depots were visualized and quantified by CT-Vol and CT-An software (SkyScan Co.).
| Histological analysis
Formalin-fixed visceral WAT, interscapular BAT and liver were embedded in paraffin, and 4-μm-thick sections were stained with hematoxylin and eosin using 17-week-old mice. Sections were analyzed at ×100 magnification using an Eclipse 80i microscope (Nikon Corp.), and digital images (1,280 × 960 pixels) were obtained using NIS Elements D image analysis software (Nikon Corp.). The adipocytes' sizes were determined with Lumina Vision 2.20 (Mitani Inc.), measuring at least 1000 cells from each group of 8-10 mice. Oil droplet areas in BAT and liver were also measured with the same software. Genes to Cells NOSHIRO et al. (Ijpenberg, Jeannin, Wahli, & Desvergne, 1997) were prepared by annealing the oligonucleotide pair of the consensus PPRE shown below. The fragments were used to construct a reporter plasmid using pGL4 with a minimal promoter (Promega). The construction of the expression plasmid (pcDNA3.1) for mouse DEC1 has been described previously . The expression plasmids (pCMX) for mouse PPARγ and human RXRα were kindly supplied by Dr. M. Makishima (Nihon University, Japan). The oligonucleotides used for the consensus PPRE × 3 were upper strand: 5′ -CTAGCAGGGGACCAGGACAAAGGTCACGTTCGGG AGTCGACAGGGGACCAGGACAAAGGTCACGTTCG GGAGTCGACAGGGGACCAGGACAAAGGTCACGTT CGGGA-3′ and lower strand: 5′-TCGATCCCGAACGTGA CCTTTGTCCTGGTCCCCTGCGACTCCCGAACGTGAC CTTTGTCCTGGTCCCCTGTCGACTCCCGAACGTGAC CTTTGTCCTGGTCCCCTG-3′. Mouse 3T3-L1 cells were inoculated at 1 × 10 4 cells/well in 96-well plastic plates and cultured in Dulbecco's modified Eagle's medium (Sigma-Aldrich) containing 1 mg/ml d-glucose, 10% (v/v) fetal bovine serum (FBS) (HyClone), 50 μg/ml ascorbic acid, 32 U/ml penicillin and 40 μg/ml streptomycin at 37°C in a 5% CO 2 incubator. For adipogenic differentiation of 3T3-L1 preadipocytes, the medium was changed to adipogenic induction medium containing 5% FBS, 1 μM dexamethasone (Sigma-Aldrich), 500 μM 3-isobutyl-1-methylxanthine (Wako), 200 μM indomethacin (Wako), 5 μM troglitazone (Wako) and 10 μg/ml insulin (Wako) (Pittenger et al., 1999) . The medium was replaced with adipogenesis maintenance medium containing 10% FBS and 10 μg/ml insulin every 2 days after adipogenic induction. 3T3-L1 adipocytes were used for reporter assays 6 days after induction. DNA transfection of the luciferase constructs with the internal control plasmid pRL-TK and the expression plasmids was carried out using Lipofectamine-LTX transfection reagent (Life Technologies). The ligands troglitazone (1 μM) and 9-cis retinoic acid (0.1 μM) for PPARγ and RXRα, respectively, dissolved in dimethyl sulfoxide, were added to the culture medium (Gottlicher, Widmark, Li, & Gustafsson, 1992; Willy et al., 1995) . Two days after transfection, the cells were harvested and the cell lysate was analyzed using dual luciferase assay reagents (Promega). Three wells were measured for each assay, and luciferase activities were normalized against internal control values. Two independent transfection experiments were carried out.
| Luciferase reporter assay
| ChIP assay
ChIP assays of PPRE using anti-DEC1 antibodies (Nakashima et al., 2008) were carried out using a ChIP Assay Kit (Upstate) according to the manufacturer's instructions. Differentiating 3T3-L1 adipocytes were used 6 days after induction. Cellular genomic DNA was cross-linked with formaldehyde and sonicated. DNA fragments were precipitated using anti-DEC1 antibodies (αDEC1) or control IgG (Co IgG). DNA samples recovered from 3T3-L1 adipocytes were subjected to PCR using the gene-specific primers listed below, to detect DEC1 binding to the PPRE region of Pparγ, Lpl and Plin1 Schoonjans et al., 1996) . The PCR primers used were as follows: Pparγ, 5′-GTTAGCAGTTTGGCACAGCTAGGT-3′ and 5′-AAAATTGGAGCCCTCCCTGAGA-3′; Lpl, 5′-CGGTA GGCAAACTGGAGTCTAAAC-3′ and 5′-GCAGAACAGT TACAAGGGGCAGAA-3′; Plin1, 5′-ATCATAGTCCCC GGCTGTTAAGCA-3′ and 5′-TGGGTGAAAGGTGACAA GGGAAAG-3′.
| Immunoprecipitation assay
HEK293 cells were cultured in Dulbecco's modified Eagle's medium containing 5% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin at 37°C in a humidified atmosphere containing 5% CO 2 . HEK293 cells in a 10-cm dish were transfected with various combinations of pFLAG-DEC1, pFLAG-CMV2, pCMX-RXRα and pCMX-PPARγ using Lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection, cells were harvested with lysis buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% NP-40) containing complete protease inhibitor cocktail (Roche). The lysates were mixed with anti-FLAG Sepharose 4B beads (Sigma-Aldrich) in the presence of a ligand (5 μM troglitazone) and rotated for 2 h at 4°C. The beads were washed three times with cold lysis buffer. The bound proteins were eluted by boiling in SDS sample buffer and were analyzed by immunoblotting with anti-DEC1 (Nakashima et al., 2008) , anti-PPARγ (Cell Signaling Technologies, #2443) or anti-RXRα antibodies (Cell Signaling Technologies, #5388). The immunoreactive proteins were visualized using IRDye ® Secondary
Antibody and the Odyssey ® Infrared Imaging System (LiCor Biosciences).
| Statistical analysis
Results were expressed as mean ± SEM. We assessed the results by the Student's t test for comparing two groups or by two-way ANOVA for multiple comparisons. A p value less than 0.05 was considered significant.
